A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells
about
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune diseaseOrigination of new immunological functions in the costimulatory molecule B7-H3: the role of exon duplication in evolution of the immune systemAlternative splicing of MALT1 controls signalling and activation of CD4(+) T cellsCytotoxic T lymphocyte antigen-4-dependent down-modulation of costimulatory molecules on dendritic cells in CD4+ CD25+ regulatory T-cell-mediated suppression.CT60 genotype does not affect CTLA-4 isoform expression despite association to T1D and AITD in northern Sweden.High levels of soluble CTLA-4 are present in anti-mitochondrial antibody positive, but not in antibody negative patients with primary biliary cirrhosis.The soluble isoform of CTLA-4 as a regulator of T-cell responses.Alternative splicing in multiple sclerosis and other autoimmune diseases.Consequences of regulated pre-mRNA splicing in the immune system.CTLA4 gene polymorphism and autoimmunity.Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of MortalityDeciphering alternative splicing and nonsense-mediated decay modulate expression in primary lymphoid tissues of birds infected with avian pathogenic E. coli (APEC)Peripheral CD300a+CD8+ T lymphocytes with a distinct cytotoxic molecular signature increase in pregnant women with chronic chorioamnionitis.Control of alternative splicing in immune responses: many regulators, many predictions, much still to learnImmunoregulatory soluble CTLA-4 modifies effector T-cell responses in systemic lupus erythematosus.Cyclophosphamide alters the gene expression profile in patients treated with high doses prior to stem cell transplantation.Therapeutic use of anti-CTLA-4 antibodies.Targeting the alternatively spliced soluble isoform of CTLA-4: prospects for immunotherapy?Immune checkpoints and their inhibition in cancer and infectious diseases.Cytotoxic T-lymphocyte-associated protein 4 gene polymorphism is related to rheumatoid arthritis in Egyptian population.Basis for molecular diagnostics and immunotherapy for esophageal cancer.The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production.Expression of CTLA-4 by human monocytes.Lack of association between sCTLA-4 levels in human plasma and common CTLA-4 polymorphisms.The soluble form of CTLA-4 from serum of patients with autoimmune diseases regulates T-cell responses.Recent advances in genetic predisposition of myasthenia gravis.Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients.The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population.The emerging role of CTLA4 as a cell-extrinsic regulator of T cell responses.Effects of allergen inhalation and oral glucocorticoid on serum soluble CTLA-4 in allergic asthmatics.Detection of circulating soluble CD28 in patients with systemic lupus erythematosus, primary Sjögren's syndrome and systemic sclerosis.CTLA-4 polymorphisms: influence on transplant-related mortality and survival in children undergoing allogeneic hematopoietic stem cell transplantation.Reduced sB7-H3 Expression in the Peripheral Blood of Systemic Lupus Erythematosus Patients.CTLA-4, an Essential Immune-Checkpoint for T-Cell Activation.In vitro Treg expansion favors the full-length splicing isoform of CTLA4.Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: results of in vitro studies.CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States.microRNA profiling in patients with abdominal aortic aneurysms: the significance of miR-155.Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population.Genetic determinants of Type 1 diabetes: immune response genes
P2860
Q28201947-74A9CB29-48DC-4C19-B2DF-A2D779734C2BQ28740426-52F8B183-11FC-4D2F-9EDD-9E4089D84209Q30385214-628E0384-ABB4-4CA0-84B3-BE453A134E2FQ33246674-BD35F923-112B-4868-93C8-F8B78CA8457CQ33271198-412E6A46-FEA1-4488-9A50-8C96A6B38B3AQ34482952-43E4671B-B9CA-49DF-A1A1-C325070C0E15Q34648178-69A018D3-5C61-4348-8A3D-BFE32BA1608BQ34762634-D38AABF6-C8BD-4123-B812-96DF294D724BQ35968460-79DA5EF0-BB2F-4AB1-A299-65E40069BA57Q36079873-58A9EE05-33E9-4B50-A4EC-F5CF916FC173Q36240333-D50647AC-84E5-4D7B-907E-8DA12C1D3AB0Q36299964-F8666FA3-71BA-4EB1-AA12-2AFE33438F6AQ36342271-1310AD36-0A52-45DA-866C-F6E2675F9F64Q36751866-5C7DA95A-F351-4993-BB10-D085B7915C33Q37150868-AE64A163-1C0C-4F27-94F9-25991329AA0DQ37505854-15252D7F-902A-4CAD-AFE3-5D1F9DD05825Q38231154-E92BAF75-4877-4032-B0CC-B12809DEF373Q38271877-16B8B7BB-6569-4A03-8044-5FF5F29467E5Q38845026-74413261-37DB-411A-BF17-7E214B179DF5Q39000690-6AA09D46-FCC5-4ACF-83B2-0C66C4587630Q39006844-39FAC6AA-3944-4A6D-9920-27F6C551E4A2Q39157852-873238E9-FA78-49EE-8EE8-387F4497CBE9Q40751320-0BD33D59-8314-4B02-9DFA-08E5A3AE7A1EQ41191163-08384952-4FEA-4341-BAEC-4CAAD87F5A47Q41816262-5266F69E-6C00-44C5-A5AF-A03321FC5B82Q41953614-048F3C89-F8EB-4CE7-892A-51F7F7B9FF4CQ42267746-FA92F1A2-C467-43F3-B0E5-DD2C3B33FF59Q43812054-720F4690-5305-4CDE-A66C-09CE9C82F66BQ44393406-4A758807-5FF8-4275-95E9-1D48926B1C77Q46474231-3B81F572-981F-46C6-B291-82063572B401Q47759350-3B0E1701-0D53-442E-B105-0F3F18FF9DF1Q48239167-1D672D19-6CFB-464C-9AA4-2717BE5FDBC1Q49176886-DFD68835-CAC0-4813-BED9-30C71AC56987Q50125551-C52C4119-299F-4CDF-BC11-E4BA22293E1DQ50241795-82DC8FE7-9869-44BA-803B-46E797F98DFDQ50850551-7EB61096-4692-4DFE-8314-79F1E5294657Q53631219-AF8A93FD-B365-4198-A495-6F4F764F1B7AQ54234041-D762860B-A232-4639-95E1-E8821E45AE37Q54264728-9F7F4338-CB7C-4C6B-9FA8-BEF8F475F6BCQ56806352-FB071AB6-7071-4C00-BBE6-AF78EF295742
P2860
A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells
description
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article
@en
im November 1999 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel (gepubliceerd in 1999-11)
@nl
наукова стаття, опублікована в листопаді 1999
@uk
مقالة علمية (نشرت في نوفمبر 1999)
@ar
ലേഖനം
@ml
name
A soluble form of CTLA-4 gener ...... by nonstimulated human T cells
@ast
A soluble form of CTLA-4 gener ...... by nonstimulated human T cells
@en
type
label
A soluble form of CTLA-4 gener ...... by nonstimulated human T cells
@ast
A soluble form of CTLA-4 gener ...... by nonstimulated human T cells
@en
prefLabel
A soluble form of CTLA-4 gener ...... by nonstimulated human T cells
@ast
A soluble form of CTLA-4 gener ...... by nonstimulated human T cells
@en
P2093
P1476
A soluble form of CTLA-4 gener ...... by nonstimulated human T cells
@en
P2093
Amélie Benoit de Coignac
Giovanni Magistrelli
Jean-François Gauchat
Jean-Yves Bonnefoy
Nathalie Herbault
Pascale Jeannin
Yves Delneste
P304
P356
10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y
P407
P577
1999-11-01T00:00:00Z